Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services entities : Pfizer, inc. save search
Pyxis Oncology Reports Financial Results for the First Quarter 2023 and Provides Corporate Update
Published: 2023-05-11 (Crawled : 11:00) - globenewswire.com
PYXS | $4.48 -1.1% -1.12% 380K
|
Professional, Scientific, and T...
|
| O: 0.67%
H: 6.0%
C: 1.33%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -1.83%
H: 0.13%
C: -0.05%
update financial results
Pyxis Oncology Announces Dosing of First Subject in Phase 1 Trial of PYX-201, a Novel ADC for Solid Tumors
Published: 2023-03-16 (Crawled : 12:20) - biospace.com/
PYXS | $4.48 -1.1% -1.12% 380K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 7.46%
C: 7.46%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.55%
H: 1.07%
C: 0.77%
pyx-201 tumors trial phase 1
Regenerative Medicine Market to be Worth $180.87 Billion by 2030: Grand View Research, Inc.
Published: 2023-02-14 (Crawled : 10:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 0.43%
H: 1.52%
C: -1.88%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
USRM | $0.0001 1300.0% 290K
|
Professional, Scientific, and T...
|
| O: 2.22%
H: 4.35%
C: 4.35%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.23%
H: 0.25%
C: -0.84%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.27%
H: 0.42%
C: -0.21%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.04%
H: 0.93%
C: -0.85%
NUVA | $39.75 -2.24% -2.29% 0
|
Health Technology
|
| O: -0.16%
H: 2.24%
C: 0.79%
MDXG | $6.505 2.28% 2.23% 750K
|
Health Technology
|
| O: -1.3%
H: 2.85%
C: 2.19%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 0.3%
H: 0.94%
C: 0.6%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.39%
H: 0.12%
C: -0.69%
market
Global Hemoglobinopathies Market Report 2022: Rising Cases in Under-Developed Countries Boosts Growth
Published: 2023-01-16 (Crawled : 14:00) - prnewswire.com
ALNY | $146.06 0.19% 0.18% 540K
|
Health Technology
| Email alert
Add to watchlist
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
EMMA | $0.0921 385.44% 66K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
| Email alert
Add to watchlist
DHR | $253.11 7.21% 0.0% 6.8M
|
Health Technology
| Email alert
Add to watchlist
GBT | $68.49 0.02% -0.02%
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
| Email alert
Add to watchlist
global report growth market
Pfizer Opts In to LianBio Rights to Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir in Mainland China, Hong Kong, Macau, and Singapore
Published: 2022-12-19 (Crawled : 12:20) - globenewswire.com
LIAN | $4.92 0.41% 0.41% 410K
|
Professional, Scientific, and T...
|
| O: 1.48%
H: 34.31%
C: 21.9%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.23%
H: 0.56%
C: -0.31%
candidate respiratory virus
High Potency APIs Global Market Expected to Grow from $19,772.2 Million in 2021 to $30,405.1 Million in 2026
Published: 2022-08-18 (Crawled : 15:00) - prnewswire.com
LZAGF | $541.144 -19.1% 24
|
Health Technology
|
| O: -0.82%
H: 1.51%
C: 1.5%
LZAGY | $55.69 0.02% 29K
|
Professional, Scientific, and T...
|
| O: 1.36%
H: 0.6%
C: 0.2%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.24%
H: 0.26%
C: -1.64%
global expected market
LAMEA Peptide Therapeutics Market Report 2022: Annual Growth of 12.5% Expected Through 2028
Published: 2022-08-05 (Crawled : 15:20) - prnewswire.com
LZAGF | $541.144 -19.1% 24
|
Health Technology
|
| O: -4.5%
H: 0.0%
C: 0.0%
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: -6.04%
H: 2.59%
C: 2.59%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.16%
H: 0.0%
C: 0.0%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: -4.45%
LZAGY | $55.69 0.02% 29K
|
Professional, Scientific, and T...
|
| O: -3.78%
H: 0.57%
C: 0.36%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -0.65%
H: 0.29%
C: 0.0%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.44%
H: 0.66%
C: -0.75%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.16%
H: 0.71%
C: 0.56%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -1.26%
H: 1.36%
C: 1.2%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -1.08%
H: 0.94%
C: -0.38%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.63%
H: 0.63%
C: 0.24%
report expected therapeutics growth market
Ambrx Biopharma Inc. Appoints Janet Loesberg to Board of Directors
Published: 2022-06-06 (Crawled : 14:00) - biospace.com/
AMAM 4 | $28.0 0.0% 1.4M
|
Professional, Scientific, and T...
|
| O: -2.0%
H: 1.4%
C: -0.64%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 1.12%
H: 0.99%
C: 0.13%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
biopharma
LianBio’s Partner ReViral Enters into Acquisition Agreement with Pfizer
Published: 2022-04-07 (Crawled : 00:00) - globenewswire.com
LIAN | $4.92 0.41% 0.41% 410K
|
Professional, Scientific, and T...
|
| O: 1.11%
H: 2.0%
C: -7.69%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.56%
H: 1.33%
C: 0.58%
acquisition
Aerovate Therapeutics Announces Second Quarter 2021 Financial Results
Published: 2021-08-16 (Crawled : 12:15) - globenewswire.com
AVTE M | $23.235 4.8% 4.58% 150K
|
Professional, Scientific, and T...
|
| O: -8.86%
H: 4.83%
C: 3.51%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 1.54%
H: 1.53%
C: 1.41%
VYGR | News | $7.645 0.99% 0.98% 370K
|
Health Technology
|
| O: -3.31%
H: 2.05%
C: -1.37%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.56%
H: 0.81%
C: 0.62%
financial results results therapeutics
Janux Therapeutics Appoints Shahram Salek-Ardakani, Ph.D., Chief Scientific Officer
Published: 2021-07-19 (Crawled : 18:00) - biospace.com/
JANX | $49.86 2.01% 1.97% 710K
|
Professional, Scientific, and T...
|
| O: -1.61%
H: 2.28%
C: 1.25%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.17%
H: 0.7%
C: 0.2%
therapeutics
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.